Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Osteopore Ltd. ( (AU:OSX) ) has provided an announcement.
Osteopore Limited’s craniomaxillofacial and oculoplastic implants have been added to Singapore’s Ministry of Health Implant Subsidy List, making these advanced regenerative treatments more accessible and affordable in public healthcare. This inclusion is a significant advancement in enhancing patient care and optimizing healthcare resources, demonstrating Osteopore’s commitment to expanding access to innovative healthcare solutions.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean regenerative medicine company specializing in 3D-printed biomimetic and bioresorbable implants. The company focuses on developing implants for craniomaxillofacial and oculoplastic applications, designed to support natural tissue regeneration and bone healing.
YTD Price Performance: 0%
Average Trading Volume: 245,725
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$4.09M
Find detailed analytics on OSX stock on TipRanks’ Stock Analysis page.